DCF — GARNET HEALTH MEDICAL CENTER
Enterprise Value: $-655.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-655.0M
Enterprise Value
$-213.3M
PV of Cash Flows
$-441.7M
PV of Terminal Value
$-711.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $591.3M | $-37.5M | -6.0% | $-62.5M | $-56.8M |
| Year 2 | $609.0M | $-32.5M | -5.0% | $-58.3M | $-48.2M |
| Year 3 | $627.3M | $-27.2M | -4.0% | $-53.8M | $-40.4M |
| Year 4 | $646.1M | $-24.8M | -4.0% | $-52.1M | $-35.6M |
| Year 5 | $665.5M | $-23.9M | -4.0% | $-52.0M | $-32.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-655.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$574.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.06837524301033127
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5